This prediction is expected because no previous studies showing a dysregulation of mGluR7 in FXS patients or animal models have been reported, although our results show a slightly altered surface expression pattern of mGluR7a and mGluR7b in Fmr1 KO mice. This evidence concerns the gene GRM7 and fragile X syndrome.